Janssen CM-strategy: A Story of Multiple Platforms From R&D to Commercial

03rd December 2020 | 10:00am CET | Jeroen Geens, Engineering Technical Director at Janssen Research & Development |BOOK FREE SEAT FOR THIS WEBINAR

After initial CM projects and successes for specific compounds in its commercial portfolio, Janssen defined in 2015 a vision to make continuous manufacturing the default platform for the development and launch of its entire future portfolio of oral solid dosage forms.
The Janssen vision has been translated in an end-to-end CM strategy and deployment plan, across R&D and Operations, demonstrating the need to have access to different CM technology platforms in order to achieve this goal. As part of this strategy, Janssen invested in its Mirror platform, redesigned the development approach in view of Continuous Manufacturing and built external partnerships.
Important in successful deployment of the CM strategy is to continuously stick to the initial vision, despite the many challenges on the journey. While being pragmatic but selective in accepting outliers, not to be brought on CM, Janssen is shaping its CM-platform and network not only for, but mainly through the R&D-portfolio.

Presented by Jeroen Geens, Engineering Technical Director at Janssen Research & Development

Jeroen Geens holds a PhD in Chemical Engineering from Leuven University (Belgium). He joined Janssen Supply Chain in 2005 in the new technology group in SM API-manufacturing, with a focus on flow chemistry, spray drying and PAT. In 2010 he joined Janssen R&D, working in several roles in the DP Pilot Plant of Janssen’s Clinical Supply Chain, working on new product introductions for clinical manufacturing (Beerse, Belgium). In his current role of Engineering Technical Director, he works on the strategy implementation of new technologies for DP-development and manufacturing with a key focus on CM-deployment. After his initial engagement in shaping the R&D CM-platform, started 2014, he is now supporting the new product teams in bringing Janssen’s portfolio on CM-technology, while also acting as one of the lead R&D-partners for Janssen Supply Chain in the further implementation of their CM-capabilities and network strategy.

We will not sell your information to a third party. See our Privacy Policy